SC Filed 2023-08-11 Event — SEC 0001193125-23-210724 →

Longitude Capital Partners III, LLC → Inozyme Pharma, Inc.

Stake: — Shares: —

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

7 13D/G filings on this issuer

6 other filings besides this one

Filer Track Record

11 filings by this filer

10 other filings in the data moat

Short Interest

—

Not in latest FINRA snapshot

Other 13D/G Filings on Inozyme Pharma, Inc.

Filed	Form	Filer	Stake	Shares
2025-08-27	SCHEDULE	Pivotal bioVenture Partners Fund I, L.P.	—	—	view →
2023-05-23	SC	Pivotal bioVenture Partners Fund I, L.P.	—	—	view →
2023-04-04	SC	Pivotal bioVenture Partners Fund I, L.P.	—	—	view →
2021-03-30	SC	Novo Holdings A/S	—	—	view →
2021-02-01	SC	Novo Holdings A/S	—	—	view →
2020-10-05	SC	Novo Holdings A/S	—	—	view →

Other Filings by Longitude Capital Partners III, LLC

Filed	Form	Issuer	Stake	Shares
2023-10-30	SC	Tourmaline Bio, Inc.	—	—	view →
2022-02-07	SC	89bio, Inc.	—	—	view →
2022-02-04	SC	Sierra Oncology, Inc.	—	—	view →
2021-11-08	SC	Sierra Oncology, Inc.	—	—	view →
2021-01-26	SC	Axonics Modulation Technologies, Inc.	—	—	view →
2020-11-25	SC	89bio, Inc.	—	—	view →
2020-08-20	SC	Axonics Modulation Technologies, Inc.	—	—	view →
2020-07-20	SC	89bio, Inc.	—	—	view →
2020-06-05	SC	Molecular Templates, Inc.	—	—	view →
2019-12-05	SC	Molecular Templates, Inc.	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. $1,500/mo. Pilots welcome.

Request a pilot →